newsfilter
← Latest News
Business Wire·

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

More than 1,400 participants across 65+ countries underscores accelerating adoption of model-informed workflows and growing demand for applied modeling expertise Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"